EUVIMEDEUVIMED entdecken
Open Access

Fluticasone Propionate-loaded Black Cumin Oil NLCs with Dual Deposition/Permeation Capabilities for Enhanced Psoriasis Management

Mohamed Ashraf iD, Hossam S El-Sawy iD, Ghada M El Zaafarany iD, Mona M A Abdel-Mottaleb iD

Advanced Pharmaceutical Bulletin · 19.05.2026

DOI: 10.34172/apb.47080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 19.05.2026. Verfasst von Mohamed Ashraf und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Egyptian Russian University, Cairo 11829, Egypt. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to enhance the therapeutic effect of fluticasone (FP) for psoriasis using black cumin oil-based nanostructured lipid carriers (NLCs) with dual deposition/permeation capabilities to achieve high drug localization within the viable skin layers (deposition) for targeted topical action, while concurrently facilitating efficient drug flux through the skin (permeation) to address the full depth of psoriatic plaques.

Methods

Oil selection followed a preliminary NLC optimization study. Characterization used microscopy, FTIR, DSC, ex vivo skin permeation and deposition, and in vivo pharmacodynamics with imiquimod-induced psoriatic mice.

Results

The optimized NLC showed a size of 171.3 nm, a PDI of 0.37, and a zeta potential of -32.3 mV. Ex-vivo data showed dual local/systemic distribution, with FP deposition in the stratum corneum and epidermis, plus superior permeation versus marketed cream. An in vivo study revealed PASI score improvement up to 77%. IL-6 and IL-1α levels were significantly reduced. Histology showed inflammation decline.

Conclusion

Results demonstrated improved anti-psoriatic action using the dual distribution/combinatorial approach with the optimized formulation. The data confirmed that the black cumin oil-based NLC formulation offers better outcomes than the standard cream by enhancing FP skin targeting, penetration, and anti-inflammatory response in psoriatic models.

Schlagwörter

Stichwörter der Autor:innen

Black cumin oilFluticasone propionateImiquimod modelInflammatory cytokinesNanostructured lipid carriersPsoriasis

Autor:innen und Institutionen

  • Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Egyptian Russian University, Cairo 11829, Egypt.
  • Department of Pharmaceutics, College of Pharmacy, University of Kut, Wasit, 52001, Iraq.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
  • Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, Besançon, France.

ORCID-Profile: Mohamed Ashraf, Hossam S El-Sawy, Ghada M El Zaafarany, Mona M A Abdel-Mottaleb

Zitieren

APA

Ashraf, M., El-Sawy, H. S., El Zaafarany, G. M., & Abdel-Mottaleb, M. M. A. (2026). Fluticasone Propionate-loaded Black Cumin Oil NLCs with Dual Deposition/Permeation Capabilities for Enhanced Psoriasis Management. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.47080

Vancouver

Ashraf M, El-Sawy HS, El Zaafarany GM, Abdel-Mottaleb MMA. Fluticasone Propionate-loaded Black Cumin Oil NLCs with Dual Deposition/Permeation Capabilities for Enhanced Psoriasis Management. Advanced Pharmaceutical Bulletin. 2026. doi:10.34172/apb.47080

BibTeX
@article{Ashraf2026,
  author = {Ashraf, Mohamed and El-Sawy, Hossam S and El Zaafarany, Ghada M and Abdel-Mottaleb, Mona M A},
  title = {Fluticasone Propionate-loaded Black Cumin Oil NLCs with Dual Deposition/Permeation Capabilities for Enhanced Psoriasis Management},
  journal = {Advanced Pharmaceutical Bulletin},
  year = {2026},
  doi = {10.34172/apb.47080}
}
Kostenlos starten →